Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Camille Chaumais

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Current Opinion in Pulmonary Medicine|June 23, 2017
Pulmonary arterial hypertension induced by tyrosine kinase inhibitorsJason Weatherald, Marie-Camille Chaumais, David Montani
Handbook of Experimental Pharmacology|October 5, 2013
Calcium-channel blockers in pulmonary arterial hypertensionMarie-Camille Chaumais, Elise Artaud Macari, Olivier Sitbon
Current Opinion in Pulmonary Medicine|July 9, 2016
Interferon-induced pulmonary hypertension: an updateLaurent Savale, Marie-Camille Chaumais, Caroline O'Connell, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 16, 2013
Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatmentMarie-Camille Chaumais, Swanny Perrin, Olivier Sitbon, et al.
Basic & Clinical Pharmacology & Toxicology|January 24, 2026
Evaluation of the Perception of Deprescribing by French Pharmacy Students: A National Observational StudyJean-François Huon, Baptiste Blanchard, Laurence Spiesser-Robelet, et al.
Pediatric Nephrology (Berlin, Germany)|April 28, 2009
Fatal pulmonary fibrosis after rituximab administrationMarie-Camille Chaumais, Arnaud Garnier, François Chalard, et al.
Presse Medicale (Paris, France : 1983)|May 4, 2011
[Novel immunopathological approaches to pulmonary arterial hypertension]Frédéric Perros, David Montani, Peter Dorfmüller, et al.
Presse Medicale (Paris, France : 1983)|August 27, 2013
Drugs induced pulmonary arterial hypertensionAndrei Seferian, Marie-Camille Chaumais, Laurent Savale, et al.
Chemotherapy|May 11, 2012
Animal model methodology: immunocompetent or leucopenic rats, which is the best? Results from a model of experimental pneumonia due to derepressed cephalosporinase-producing Enterobacter cloacaeAnne Jacolot, Claire Judel, Marie-Camille Chaumais, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 29, 2008
Unusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitisYannick Nochez, Sophie Arsene, Chantal Le Guellec, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Current Opinion in Pulmonary Medicine|June 23, 2017
Pulmonary arterial hypertension induced by tyrosine kinase inhibitorsJason Weatherald, Marie-Camille Chaumais, David Montani
Handbook of Experimental Pharmacology|October 5, 2013
Calcium-channel blockers in pulmonary arterial hypertensionMarie-Camille Chaumais, Elise Artaud Macari, Olivier Sitbon
Current Opinion in Pulmonary Medicine|July 9, 2016
Interferon-induced pulmonary hypertension: an updateLaurent Savale, Marie-Camille Chaumais, Caroline O'Connell, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 16, 2013
Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatmentMarie-Camille Chaumais, Swanny Perrin, Olivier Sitbon, et al.
Basic & Clinical Pharmacology & Toxicology|January 24, 2026
Evaluation of the Perception of Deprescribing by French Pharmacy Students: A National Observational StudyJean-François Huon, Baptiste Blanchard, Laurence Spiesser-Robelet, et al.
Pediatric Nephrology (Berlin, Germany)|April 28, 2009
Fatal pulmonary fibrosis after rituximab administrationMarie-Camille Chaumais, Arnaud Garnier, François Chalard, et al.
Presse Medicale (Paris, France : 1983)|May 4, 2011
[Novel immunopathological approaches to pulmonary arterial hypertension]Frédéric Perros, David Montani, Peter Dorfmüller, et al.
Presse Medicale (Paris, France : 1983)|August 27, 2013
Drugs induced pulmonary arterial hypertensionAndrei Seferian, Marie-Camille Chaumais, Laurent Savale, et al.
Chemotherapy|May 11, 2012
Animal model methodology: immunocompetent or leucopenic rats, which is the best? Results from a model of experimental pneumonia due to derepressed cephalosporinase-producing Enterobacter cloacaeAnne Jacolot, Claire Judel, Marie-Camille Chaumais, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 29, 2008
Unusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitisYannick Nochez, Sophie Arsene, Chantal Le Guellec, et al.
Pageof 6